Europe Dialysis Market size surpassed USD 24 billion in 2020 and is anticipated to exhibit a CAGR of 3.6% from 2021 to 2027.

Get more details on this report - Request Free Sample PDF

The rising old age population is one of the primary factors driving the market progress in Europe. For instance, as per Eurostat statistics, in 2020, more than one fifth (20.6%) of the EU population is aged 65 and above whereas the share of people aged 80 years and above is expected to rise from 5.9% in 2020 to 14.6% in 2100. In elderly people, kidney diseases or disturbance in normal kidney function can also lead to other health problems such as diabetes, heart problems, and blood pressure. Hence, the early treatment of kidney disorders is very crucial. Also, rising cases of end-stage renal diseases, increase in funding for the development of new products with advanced technology, and rapid growth in the cases of kidney failure will augment the market demand.

Europe Market, By Type

The hemodialysis segment accounted for 91% Europe dialysis market share in 2020. Patients prefer hemodialysis (HD) as it is of higher dialysis efficacy. Also, availability of simpler hemodialysis machines have made home hemodialysis convenient, so with special training and someone to help the patient undergoing dialysis, one may be able to do hemodialysis at home.

Europe Market, By Product & Services

Get more details on this report - Request Free Sample PDF

Equipment segment value in the Europe dialysis market was more than USD 1.8 billion in 2020, attributed to rising number of people undergoing dialysis in the region. According to Kidney care UK, around 30,000 people in the country are on dialysis. This will create demand for dialysis machines in the country. Also, for safe and effective hemodialysis, high volume of ultrapure water is needed. Thus, demand for sequential and progressive water purification system has increased.

Europe Market, By End-use

The in-center dialysis segment will likely showcase 3.5% growth rate during the forecast timeframe. In-center dialysis is preferred as it takes less time, around 3 to 4 hours. Also, the patient is in supervision of professionals and around people who are receiving similar treatment. Moreover, due to less development of home dialysis in many European countries as well as insufficient training required for home dialysis, the preference for in-center dialysis is high. For instance, in France, home dialysis is not sufficiently developed and only 7% of people receive home dialysis.

Europe Market, By Country

Germany dominated the Europe dialysis market, growing at 3% CAGR through 2027. Favourable reimbursement policies and presence of key companies will propel the country-level industry progression. Also, Germany is one of the countries that have a high prevalence of kidney failures. Nearly 80,000 patients in the country are suffering with end stage renal disease (ESRD). These patients are treated with either hemodialysis or peritoneal dialysis.

Competitive Industry Landscape

Key participants involved in the Europe dialysis market include DaVita, Baxter, Medtronic, B. Braun, Fresenius Kabi, Physidia, Diaverum, Nxstage Medical Inc., Merck Kgaa, Cantel Medical, and others.